ResearcherImperial College LondonNo recent work listed

Rajpal S. Burmi

ORCID-verified (high confidence)As of 10 November 2026

Matched on ORCID iD 0000-0001-9979-3925; OpenAlex author ID A5080051703.

Their work

Papers: 1 (first author 1, last author 0)
Trials: 0
Grants: 0
Collaborators: 3

Papers, trials and grants by year

2019: 1 paper

Papers 1

Combined inhibition of the PI3K/mTOR/MEK pathway induces Bim/Mcl-1-regulated apoptosis in pancreatic cancer cells. First author DOI 10.1080/15384047.2018.1504718 ↗

Closest collaborators

The 3 strongest of 3 ranked by shared papers, trials and grants, with recent and small-team work weighing most.

Elaina N. Maginn · 1 shared paper, 2019
- Paper Combined inhibition of the PI3K/mTOR/MEK pathway induces Bim/Mcl-1-regulated apoptosis in pancreatic cancer cells. DOI 10.1080/15384047.2018.1504718 ↗
Euan A. Stronach · 1 shared paper, 2019
- Paper Combined inhibition of the PI3K/mTOR/MEK pathway induces Bim/Mcl-1-regulated apoptosis in pancreatic cancer cells. DOI 10.1080/15384047.2018.1504718 ↗
Harpreet Singh Wasan · 1 shared paper, 2019
- Paper Combined inhibition of the PI3K/mTOR/MEK pathway induces Bim/Mcl-1-regulated apoptosis in pancreatic cancer cells. DOI 10.1080/15384047.2018.1504718 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.